Table 1.

Clinicopathological information of the glioma patients.

Patients	Gender	Age (years)	Histology	WHO grade	IDH1	IRS (MYD88)	IRS (CD163)
P1	M	47	Astrocytoma	Ii	Mutant	0	1
P2	M	37	Oligodendroglioma	Ii	Mutant	2.2	1
P3	M	44	Oligodendroglioma	Ii	Mutant	0	2
P4	F	61	Oligodendroglioma	Ii	Mutant	1	2
P5	M	54	Astrocytoma	Ii	Mutant	2	1
P6	M	35	Oligodendroglioma	Ii	Mutant	0	2
P7	F	33	Astrocytoma	Ii	Mutant	3	2
P8	F	58	Astrocytoma	Ii	Wild	2.2	2
P9	M	34	Astrocytoma	Ii	Wild	3	2
P10	F	12	Oligodendroglioma	Ii	Wild	0	2
P11	M	32	Astrocytoma	Ii	Wild	2	4
P12	F	27	Anaplastic oligodendroglioma	Iii	Mutant	4	2.8
P13	M	27	Anaplastic astrocytoma	Iii	Wild	8	4.5
P14	F	50	Anaplastic astrocytoma	Iii	Wild	8	4.4
P15	M	29	Anaplastic astrocytoma	Iii	Wild	6.4	4
P16	F	68	Anaplastic astrocytoma	Iii	Wild	8	6
P17	F	75	Anaplastic astrocytoma	Iii	Wild	8.8	6
P18	M	41	Glioblastoma	Iv	Mutant	8.4	6
P19	M	39	Glioblastoma	Iv	Wild	11.2	8.4
P20	M	64	Glioblastoma	Iv	Wild	12	4
P21	M	42	Glioblastoma	Iv	Wild	12	8.4
P22	M	47	Glioblastoma	Iv	Wild	11.2	12
P23	F	56	Glioblastoma	Iv	Wild	12	6
P24	M	34	Glioblastoma	Iv	Wild	11.2	12
P25	F	34	Glioblastoma	Iv	Wild	11.2	6
P26	M	43	Glioblastoma	Iv	Wild	10.4	6.2
P27	F	61	Glioblastoma	Iv	Wild	10.4	12
P28	M	69	Glioblastoma	Iv	Wild	8.8	4
P29	F	49	Glioblastoma	Iv	Wild	5.6	4
P30	M	65	Glioblastoma	Iv	Wild	11.4	12
P31	M	49	Glioblastoma	Iv	Wild	10.4	12

IRS means average immune reactive score based on five random fields in each case.